Mia's Feed
Medical News & Research

Advancements in AI-Driven Ultrasound Technology Enable Better Prediction of Infant Delivery Timing

Advancements in AI-Driven Ultrasound Technology Enable Better Prediction of Infant Delivery Timing

Share this article

Innovative AI technology analyzing standard ultrasound images can now accurately predict the timing of infant delivery, marking a milestone in maternal-fetal medicine and improving pregnancy outcomes worldwide.

2 min read

Recent developments in artificial intelligence (AI) applied to ultrasound imaging are revolutionizing obstetric care by providing more accurate predictions of when a woman will deliver. Researchers from the University of Kentucky, in collaboration with ultrasound company Ultrasound AI, have published significant findings from their PAIR (Perinatal Artificial Intelligence in Ultrasound) Study in The Journal of Maternal-Fetal & Neonatal Medicine. This study demonstrates that using standard ultrasound images, AI algorithms can consistently and precisely forecast the timing of childbirth, offering a noninvasive, scalable, and efficient tool to improve pregnancy outcomes.

The AI technology was trained on a large dataset of over two million de-identified ultrasound images obtained from women who delivered at the University of Kentucky between 2017 and 2021. It predicts delivery timing without needing additional clinical data, maternal history, or operator input, making it applicable across diverse healthcare settings, from well-resourced hospitals to low-resource environments.

Key results reveal that the AI model achieved an R² of 0.95 for term births and 0.92 across all deliveries, showcasing its high accuracy. The system continuously learns from new data, improving prediction performance with successive retrainings. It also demonstrated robust performance across different stages of pregnancy and diverse patient demographics. Importantly, the AI model enhanced its capability to predict preterm births (PTB), a leading cause of neonatal mortality globally, with prediction accuracy improving from an R² of 0.48 to 0.72 after multiple retraining cycles.

This technology offers a promising step towards better anticipation of preterm labor, allowing healthcare providers to intervene earlier and tailor care more effectively. Dr. John M. O'Brien, MD, emphasized that this innovation could be especially impactful in resource-limited settings where access to maternal-fetal specialists is scarce. As stated by Robert Bunn, President of Ultrasound AI, the ability of AI to learn and refine its predictions over time heralds a new era in maternal-fetal medicine, with the potential to significantly reduce neonatal mortality and improve health outcomes worldwide.

According to Dr. O'Brien, "This is an important milestone for the field of obstetrics, as AI begins to assist in forecasting birth timing, potentially leading to earlier interventions and better care for mothers and babies. Our work signifies a foundational advance in integrating AI into standard ultrasound workflows, making predictive tools more accessible and scalable."

For further details, see the full study: Neil Patel et al, Perinatal artificial intelligence in ultrasound (PAIR) study: predicting delivery timing, DOI: 10.1080/14767058.2025.2532099.

Source: https://medicalxpress.com/news/2025-08-ai-ultrasound-images-infant-delivery.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Wristband Sensor Offers Comprehensive Monitoring for Diabetes and Heart Health

A new all-in-one wristband offers continuous monitoring of glucose, cardiovascular signals, and more, advancing diabetes and heart health management through wearable technology.

'Brain Dial' Discovered in Mice That Regulates Food, Fat, and Salt Cravings

Scientists at Columbia University have uncovered a brain region acting as a 'dial' that regulates cravings for sweets, fats, and salt in mice, opening new avenues for appetite control therapies.

Innovative Treatment Approach for Small Cell Lung Cancer Announces Clinical Trial

Researchers at Dana-Farber have developed a new drug strategy targeting cell cycle vulnerabilities in small cell lung cancer, leading to a promising clinical trial for this aggressive cancer type.

Many People Are Unaware They Have Diabetes, Highlighting the Need for Better Screening

A new global study reveals nearly half of the people with diabetes are unaware of their condition, highlighting critical gaps in diagnosis and management that pose a significant health risk worldwide.